Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Greenleaf Other companies: Pelthos Therapeutics Inc. (Director · Since at least Jul 1, 2025); Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Jan 1, 2021); Antares Pharma Inc (Director · Dec 12, 2018 – May 24, 2022 · Past); BioDelivery Sciences International Inc (Director · May 21, 2018 – Mar 22, 2022 · Past); Avalo Therapeutics, Inc. (Director · Mar 27, 2018 – Aug 7, 2019 · Past); Sucampo Pharmaceuticals Inc (Chief Executive Officer · Sep 30, 2017 – Feb 13, 2018 · Past) | Director · Jul 10, 2018 – Feb 1, 2019 · Past |
| Steven Boyd Other companies: Tenax Therapeutics, Inc. (Director · Aug 19, 2020 – May 18, 2022 · Past); Tetraphase Pharmaceuticals Inc (Director · Jan 22, 2020 – Jul 28, 2020 · Past); Vaxart, Inc. (Director · Nov 5, 2019 – Jun 26, 2020 · Past); Aytu BioPharma, Inc. (Director · Apr 18, 2019 – Mar 20, 2021 · Past); Del Frisco's Restaurant Group Inc (Director · Nov 30, 2018 – Nov 30, 2018 · Past); Avalo Therapeutics, Inc. (Director · May 19, 2017 – Mar 10, 2022 · Past) | Director · May 14, 2018 – Jul 27, 2021 · Past |
| Paul G Chaney Other companies: Sesen Bio Inc (Director · Jun 12, 2018 – Jun 12, 2018 · Past); Eleven Biotherapeutics Inc (Director · Feb 27, 2014 – May 19, 2017 · Past); Osi Pharmaceuticals Inc (Exec. VP & Pres. (OSI) Eyetech · May 1, 2006 – May 1, 2006 · Past) | Director · Feb 12, 2015 – Mar 3, 2023 · Past |
| Kenneth L Gayron Other companies: Research Solutions, Inc (Director · Since at least Dec 4, 2023); Avid Technology Inc (EVP, CFO & Corp Treasurer · Jun 15, 2022 – Nov 7, 2023 · Past) | Director · Mar 3, 2023 – Sep 29, 2023 · Past |
| Lisa Walters-Hoffert Other companies: Flux Power Holdings, Inc. (Director · Since at least Jun 28, 2019); Dare Bioscience, Inc. (Chief Financial Officer · Jul 19, 2017 – Jan 24, 2023 · Past) | Director · Since at least Jul 1, 2024 |
| Praveen Tyle Other companies: Skye Bioscience, Inc. (Director · Jul 22, 2021 – Feb 29, 2024 · Past); Lexicon Pharmaceuticals, Inc. (EVP, R&D · Feb 11, 2021 – Feb 28, 2021 · Past) | Director · Since at least Feb 1, 2021 |
| Eric J. Daniels Other companies: Plus Therapeutics, Inc. (Chief Development Officer · Since at least Apr 9, 2026) | Chief Development Officer · Since at least Oct 21, 2021 |
| Erin Parsons Other companies: Alimera Sciences Inc (Director · Jan 4, 2023 – Sep 16, 2024 · Past) | Director · Since at least Mar 3, 2023 |
| Aron Shapiro | Director · Since at least Sep 29, 2023 |
| Bernard Malfroy-Camine | Director · Jul 10, 2018 – Feb 1, 2021 · Past |
| Brian M. Strem | President & Chief Executive Officer · Since at least Jul 26, 2021 |
| Carmine Stengone | Director · Since at least Nov 5, 2026 |
| David Hollander | Director · Since at least Nov 5, 2026 |
| Keith J. Lane | Executive Vice President of Clinical Development and Regulatory Affairs · Since at least Sep 8, 2026 |
| Melissa Tosca | Chief Financial Officer · Since at least Sep 13, 2022 |
| Michael P Manzo | VP of Engineering · Feb 28, 2018 – Aug 3, 2021 · Past |
| Morton Goldberg | Director · Aug 28, 2015 – Feb 1, 2021 · Past |
| Ryan Randall Brenneman | Chief Financial Officer · Apr 25, 2016 – Jul 18, 2016 · Past |
| Stefan Sperl | Executive Vice President of CMC and Operations · Since at least Nov 4, 2026 |